Yüklüyor......
Novel Non-Congeneric Derivatives of the Choline Kinase Alpha Inhibitor ICL-CCIC-0019
Choline kinase alpha (CHKA) is a promising target for the development of cancer therapeutics. We have previously reported ICL-CCIC-0019, a potent CHKA inhibitor with high cellular activity but with some unfavorable pharmacological properties. In this work, we present an active analogue of ICL-CCIC-0...
Kaydedildi:
| Yayımlandı: | Pharmaceutics |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8309005/ https://ncbi.nlm.nih.gov/pubmed/34371769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13071078 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|